50
Participants
Start Date
November 30, 2008
Primary Completion Date
October 31, 2016
Study Completion Date
October 31, 2016
Carboplatin
Carboplatin (IV) 3 AUC on day 1 and day 15 every 4 weeks for 6 cycles
Bevacizumab
Bevacizumab (IV) 10 mg/kg on day 1 and day 15 every 4 weeks for 6 cycles Followed by Bevacizumab (IV) 15 mgr/Kgr on day 1 every 3 weeks until disease progression
Paclitaxel
Paclitaxel (IV) 140 mg/m2,on day 1 and day 15 every 4 weeks for 6 cycles
University Hospital of Heraklion, Dep of Medical Oncology, Heraklion
University General Hospital of Alexandroupolis, Alexandroupoli
"IASO General Hospital of Athens, 1st Dep of Medical Oncology", Athens
"Laikon General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine", Athens
"Metaxa's Anticancer Hospital of Piraeus, 1st Dep of Medical Oncology", Athens
401 Military Hospital of Athens, Athens
Air Forces Military Hospital of Athens, Athens
State General Hospital of Larissa, Dep of Medical Oncology, Larissa
"Diabalkaniko hospital, Thessaloniki", Thessaloniki
"Theagenion Anticancer Hospital of Thessaloniki, 2nd Dep of Medical Oncology", Thessaloniki
Lead Sponsor
Hellenic Oncology Research Group
OTHER